The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions

International Journal of Oral and Maxillofacial Surgery

Volumn 40, Issue 2, 2011, Pages 155-161

  Guneri P ^a   Epstein, J B ^b,c   Kaya, A ^d   Veral, A ^a   Kazandi, A ^a   Boyacioglu, H ^a  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d YEDITEPE UNIVERSITY   (Turkey)

Author keywords

brush biopsy; oral cancer; squamous cell carcinoma; toluidine blue

Indexed keywords

TOLONIUM CHLORIDE;

ADULT; ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL EXAMINATION; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; ORAL MUCOSAL DISEASE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; STAINING;

ADENOCARCINOMA; BIOPSY; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; ORAL ULCER; PREDICTIVE VALUE OF TESTS; TOLONIUM CHLORIDE;

EID: 79951954599     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2010.10.022     Document Type: Article

References (46)

1. AL-HASHIMI I, SCHIFTER M, LOCKHART PB, WRAY D, BRUCE AJ, CARPENTER W, EISENBERG E, EPSTEIN JB, HOLMSTRUP P, JONTELL M, LOZADA-NUR F, NAIR R, SILVERMAN B, THONGPRASOM K, THORNHILL M, WARNAKULASURIYA S, VAN DER WAAL I. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007: 103: S25.e1-S25.e12.
2. AXELL T, PINDBORG JJ, SMITH CJ, VAN DER WAAL I. An international collaborative group on oral white lesions. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. J Oral Pathol Med 1996: 25: 49-54.
3. BHOOPATHI V, KABANI S, MASCARENHAS AK. Low positive predictive value of the oral brush biopsy in detecting dysplastic oral lesions. Cancer 2009: 115: 1036-1040.
4. DRIEMEL O, KUNKEL M, HULLMANN M, VON EGGELING F, MÜLLER-RICHTER U, KOSMEHL H, REICHART TE. Diagnosis of oral squamous cell carcinoma and its precursor lesions. J Dtsch Dermatol Ges 2007: 5: 1095-1100.
5. EISEN D, FRIST S. The relevance of the high positive predictive value of the oral brush biopsy. Oral Oncol 2005: 41: 753-755.
6. EISENBERG E. Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 2000: 58: 1278-1285.
7. EPSTEIN JB, FELDMAN R, DOLOR RJ, PORTER SR. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 2003: 25: 911-921.
8. EPSTEIN JB, OAKLEY C, MILLNER A, EMERTON S, VAN DER MEIJ E, LE N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 83: 537-547.
9. EPSTEIN JB, SCIUBBA J, SILVERMAN JR S, SROUSSI HY. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 2007: 29: 948-958.
10. EPSTEIN JB, SCULLY C, SPINELLI J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992: 21: 160-163.
11. EPSTEIN JB, SILVERMAN JR S, SCUIBBA J, BRIDE M. Reply: defining the risk of premalignant lesions. Oral Oncol 2009: 45: 297-302.
12. EPSTEIN JB, SILVERMAN JR S, EPSTEIN JD, LONKY SA, BRIDE MA. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 2008: 44: 538-544.
13. EPSTEIN JB, ZHANG L, POH C, NAKAMURA H, BEREAN K, ROSIN M. Increased allelic loss in toluidine blue positive oral malignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003: 95: 45-50.
14. EPSTEIN JB, ZHANG L, ROSIN M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002: 68: 17-21.
15. GANDOLFO S, PENTENERO M, BROCOLETTI R, PAGANO M, CARROZZO M, SCULLY C. Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol 2006: 42: 89-95.
16. GRAY MGL, BURLS A, ELLEY K. The clinical effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice. A West Midlands Development and Evaluation Service Report. http://www.pcpoh.bham.ac.uk/ publichealth/wmhtac/pdf/toludine-blue.pdf; 2000.
17. GUO Z, YAMAGUCHI K, SANCHEZ- CESPEDES M, WESTRA WH, KOCH WM, SIDRANSKY D. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancies. Clin Cancer Res 2001: 7: 1963-1968.
18. HUANG MF, CHANG YC, LIAO PS, HUANG TH, TSAY CH, CHOU MY. Loss of heterozygosity of p53 gene of oral cancer detected by exfoliative cytology. Oral Oncol 1999: 35: 296-301.
19. KUJAN O, OLIVER RJ, KHATTAB A, ROBERTS SA, THAKKER N, SLOAN P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006: 42: 987-993.
20. LÓPEZ-JORNET P, CAMACHO-ALONSO F, MARTINEZ-BENEYTO Y, SEOANE-LESTON J. Influence of years of professional experience in relation to the diagnostic skill of general dental practitioners (GDPs) in identifying oral cancer and precancerous lesions. Int Dent J 2008: 58: 127-133.
21. MASHBERG A. Final evaluation of tolonium chloride rinse for screening of highrisk patients with asymptomatic squamous carcinoma. J Am Dent Assoc 1983: 106: 319-323.
22. MASHBERG A. Re-evaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous cell carcinoma: a continuing prospective study of oral cancer. Cancer 1980: 46: 758-763.
23. MEHROTRA R, GUPTA A, SINGH M, IBRAHIM R. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer 2006: 5: 11.
24. OGDEN GR, COWPE JG, GREEN MW. Detection of field change in oral cancer using exfoliative cytologic study. Cancer 1991: 68: 1611-1615.
25. OGDEN GR, COWPE OGDEN GR, MCQUEEN S, CHISHOLM DM, LANE FB. Keratin profiles of normal and malignant oral mucosa using exfoliative cytology. J Clin Pathol 1993: 46: 352-356.
26. ONOFRE MA, SPOSTO MR, NAVARRO CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001: 91: 535-540.
27. Oral Cancer Foundation. http://www.oralcancerfoundation.org/products/ detailed-brush-cytology.htm [accessed 24.04.2009].
28. PATTON LL, EPSTEIN JB, KERR AR. Adjuncts for oral cancer examination and lesion diagnosis: a systematic review of literature. J Am Dent Assoc 2008: 139: 896-905.
29. PATTON LL. The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol 2003: 39: 708-723.
30. POATE TW, BUCHANAN JA, HODGSON TA, SPEIGHT PM, BARRETT AW, MOLES DR, SCULLY C, PORTER SR. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 2004: 40: 829-834.
31. RAM S, SIAR CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial dysplasia. Int J Oral Maxillofac Surg 2005: 34: 521-527.
32. REICHART PA. Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Invest 2001: 5: 207-213.
33. RICK G. Oral brush biopsy: the problem of false positives. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003: 96: 252.
34. SCHEIFELE C, SCHMIDT-WESTHAUSEN AM, DIETRICH T, REICHART PA. The sensitivity and specificity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 2004: 40: 824-828.
35. SCUIBBA J. Improving detection of precancerous and cancerous oral lesions. J Am Dent Assoc 1999: 130: 1445-1457.
36. SILVERMAN Jr S. Early diagnosis of oral cancer. Cancer 1988: 62: 1796-1799.
37. SILVERMAN Jr S. Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 2000: 58: 1286-1288.
38. SILVERMAN S, MIGLIORATI C, BARBOSA J. Toluidine blue staining in the detection of oral precancerous and malignant lesions. Oral Surg Oral Medicine Oral Pathology 1984: 57: 379-382.
39. SVIRSKY JA, BURNS JC, CARPENTER WM, COHEN DM, BHATTACHARYYA I, FANTASIA JE, LEDERMAN DA, LYNCH DP, SCIUBBA JJ, ZUNT SL. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 2002: 50: 500-503.
40. VAN DER WAAL I. Oral lichen planus and oral lichenoid lesions: a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal 2009: 14: E310-314.
41. VAN DER WAAL I. Potentially malignant disorders of the oral and oropharyngeal mucosa: terminology, classification and present concepts of management. Oral Oncol 2009: 45: 317-323.
42. WARNAKULASURIYA KA, JOHNSON NW. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 1996: 25: 97-103.
43. WENIG BM. Keratinizing dysplasia of the upper aerodigestive tract. Pathol Case Rev 2008: 13: 9-16.
44. WENIG BM. Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variant. Mod Pathol 2002: 15: 229-254.
45. WHO COLLABORATING CENTRE FOR ORAL PRECANCEROUS LESIONS. Definitions of leukoplakia and related lesions: an aid to studies on oral precancers. Oral Surg 1978: 46: 518-539.
46. ZHANG L, WILLIAMS M, POH CF, LARONDE D, EPSTEIN JB, DURHAM S, NAKAMURA H, BEREAN K, HOVAN A, LE ND, HISLOP G, PRIDDY R, HAY J, LAM WL, ROSIN MP. Toluidine blue staining identifies high risk primary oral premalignant lesions with poor outcome. Cancer Res 2005: 65: 8017-8021.